Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,982 shares at $2.65 ($8K) on 2021-10-21, disclosed to the SEC on 2021-11-05.
Scheduled purchase ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.69 | 142 | $382 | 4.7% |
| 2 | $2.87 | 142 | $408 | 5.0% |
| 3 | $2.82 | 142 | $400 | 4.9% |
| 4 | $2.76 | 142 | $392 | 4.8% |
| 5 | $2.76 | 142 | $392 | 4.8% |
| 6 | $2.84 | 142 |
| $403 |
| 5.0% |
| 7 | $2.73 | 142 | $388 | 4.8% |
| 8 | $2.71 | 142 | $385 | 4.7% |
| 9 | $2.71 | 142 | $385 | 4.7% |
| 10 | $2.81 | 142 | $399 | 4.9% |
| 11 | $2.76 | 142 | $392 | 4.8% |
| 12 | $2.75 | 142 | $391 | 4.8% |
| 13 | $2.76 | 142 | $392 | 4.8% |
| 14 | $2.63 | 142 | $373 | 4.6% |
| 15 | $2.65 | 142 | $376 | 4.6% |
| 16 | $2.66 | 142 | $378 | 4.7% |
| 17 | $2.64 | 142 | $375 | 4.6% |
| 18 | $2.64 | 142 | $375 | 4.6% |
| 19 | $2.61 | 142 | $371 | 4.6% |
| 20 | $2.61 | 142 | $371 | 4.6% |
| 21 | $2.72 | 142 | $386 | 4.8% |
| Total | $2.72 avg | 2,982 | $8K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |